Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Twentyman

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
British Journal of Cancer|July 1, 1994
Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/RT Rhodes, M A Barrand, P R Twentyman
British Journal of Cancer|March 1, 1991
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionH M Coley, P Workman, P R Twentyman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serumM Lehnert, R de Giuli, P R Twentyman
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatinP R Twentyman, K A Wright, T Rhodes
Cancer Treatment Reports|March 1, 1978
Enhancement by hyperthermia of the effect of BCNU against the EMT6 mouse tumorP R Twentyman, J E Morgan, J Donaldson
Anti-Cancer Drug Design|December 1, 1992
Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P Workman
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P Workman
Cancer Chemotherapy and Pharmacology|January 1, 1989
Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin AH M Coley, P R Twentyman, P Workman
British Journal of Cancer|March 1, 1992
Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitroP R Twentyman, K A Wright, H M Wallace
International Journal of Radiation Oncology, Biology, Physics|September 1, 1979
The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. IV. Actinomycin-DP R Twentyman, R F Kallman, J M Brown
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|July 1, 1994
Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/RT Rhodes, M A Barrand, P R Twentyman
British Journal of Cancer|March 1, 1991
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionH M Coley, P Workman, P R Twentyman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serumM Lehnert, R de Giuli, P R Twentyman
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatinP R Twentyman, K A Wright, T Rhodes
Cancer Treatment Reports|March 1, 1978
Enhancement by hyperthermia of the effect of BCNU against the EMT6 mouse tumorP R Twentyman, J E Morgan, J Donaldson
Anti-Cancer Drug Design|December 1, 1992
Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P Workman
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P Workman
Cancer Chemotherapy and Pharmacology|January 1, 1989
Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin AH M Coley, P R Twentyman, P Workman
British Journal of Cancer|March 1, 1992
Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitroP R Twentyman, K A Wright, H M Wallace
International Journal of Radiation Oncology, Biology, Physics|September 1, 1979
The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. IV. Actinomycin-DP R Twentyman, R F Kallman, J M Brown
Pageof 16